|
|
Volumn 102, Issue 22, 2010, Pages 1690-1692
|
|
Third-generation SERMs may face uphill battle.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BAZEDOXIFENE;
BONE DENSITY CONSERVATION AGENT;
CIS 1R (4' PYRROLIDINOETHOXYPHENYL) 2S PHENYL 6 HYDROXY 1,2,3,4 TETRAHYDRONAPHTHALENE, TARTRATE SALT;
CIS-1R-(4'-PYRROLIDINOETHOXYPHENYL)-2S-PHENYL-6-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE, TARTRATE SALT;
ESTRADIOL;
ESTROGEN RECEPTOR;
INDOLE DERIVATIVE;
PYRROLIDINE DERIVATIVE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TETRALIN DERIVATIVE;
BLOOD;
BREAST TUMOR;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG EFFECT;
DRUG INDUSTRY;
ECONOMICS;
EVIDENCE BASED MEDICINE;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
HUMAN;
METABOLISM;
METHODOLOGY;
NOTE;
PATENT;
POSTMENOPAUSE OSTEOPOROSIS;
PRIMARY PREVENTION;
RISK;
UNITED STATES;
ANTICARCINOGENIC AGENTS;
BONE DENSITY CONSERVATION AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG INDUSTRY;
ESTRADIOL;
EVIDENCE-BASED MEDICINE;
FEMALE;
FRACTURES, BONE;
HUMANS;
INDOLES;
OSTEOPOROSIS, POSTMENOPAUSAL;
PATENTS AS TOPIC;
PRIMARY PREVENTION;
PYRROLIDINES;
RALOXIFENE;
RECEPTORS, ESTROGEN;
RISK;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
TETRAHYDRONAPHTHALENES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79952114471
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq477 Document Type: Note |
|
Times cited : (17)
|
|
References (0)
|
